|Articles|September 1, 2003
5-Fluorouracil Combo Promising
Author(s)Lawrence M. Prescott, Ph.D.
Chicago - The combination of oxaliplatin (Eloxatin) and a continuous infusion of 5-fluorouracil (5-FU) appears to offer a promising chemotherapeutic alternative to the presently administered cisplatin or carboplatin-based approach for the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck, Marc Debled, M.D., said at the American Society of Clinical Oncology meeting.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
3
Journal Digest: January 14, 2026
4
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
5














